Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2

Marzia Belicchi, Silvia Erratico, Paola Razini, Mirella Meregalli, Alessandra Cattaneo, Emanuela Jacchetti, Andrea Farini, Chiara Villa, Nereo Bresolin, Laura Porretti, Cristina Lenardi, Paolo Milani, Yvan Torrente

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Ex vivo expansion of hematopoietic stem cells has been explored in the fields of stem cell biology, gene therapy and clinical transplantation. Recently, we demonstrated the existence of a circulating myogenic progenitor expressing the CD133 antigen. The relative inability of circulating CD133+ stem cells to reproduce themselves ex vivo imposes substantial limitations on their use for clinical applications in muscular dystrophies. Here we report that the use of cluster-assembled nanostructured titanium dioxide (ns-TiO2) substrates, in combination with cytokine enriched medium, enables high-level expansion of circulating CD133+ stem cells in vitro. Furthermore, we demonstrate that expanded circulating CD133+ stem cells retain their in vitro capacity to differentiate into myogenic cells. The exploitation of cluster-assembled ns-TiO2 substrates for the expansion of CD133+ stem cells in vitro could therefore make the clinical application of these stem cells for the treatment of muscle diseases practical.

Original languageEnglish
Pages (from-to)5385-5396
Number of pages12
JournalBiomaterials
Volume31
Issue number20
DOIs
Publication statusPublished - Jul 2010

Fingerprint

Stem cells
Stem Cells
Cytology
Muscular Dystrophies
Gene therapy
Hematopoietic Stem Cells
Genetic Therapy
Substrates
Antigens
Cell Biology
Titanium dioxide
Transplantation
Muscle
Cytokines
Muscles
In Vitro Techniques

Keywords

  • Cell culture
  • Muscular dystrophy
  • Nanotopography
  • Stem cell
  • Surface treatment
  • Titanium oxide

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2 . / Belicchi, Marzia; Erratico, Silvia; Razini, Paola; Meregalli, Mirella; Cattaneo, Alessandra; Jacchetti, Emanuela; Farini, Andrea; Villa, Chiara; Bresolin, Nereo; Porretti, Laura; Lenardi, Cristina; Milani, Paolo; Torrente, Yvan.

In: Biomaterials, Vol. 31, No. 20, 07.2010, p. 5385-5396.

Research output: Contribution to journalArticle

Belicchi, Marzia ; Erratico, Silvia ; Razini, Paola ; Meregalli, Mirella ; Cattaneo, Alessandra ; Jacchetti, Emanuela ; Farini, Andrea ; Villa, Chiara ; Bresolin, Nereo ; Porretti, Laura ; Lenardi, Cristina ; Milani, Paolo ; Torrente, Yvan. / Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2 . In: Biomaterials. 2010 ; Vol. 31, No. 20. pp. 5385-5396.
@article{96afe44a34df44c29cc551ee90c9d8ba,
title = "Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2",
abstract = "Ex vivo expansion of hematopoietic stem cells has been explored in the fields of stem cell biology, gene therapy and clinical transplantation. Recently, we demonstrated the existence of a circulating myogenic progenitor expressing the CD133 antigen. The relative inability of circulating CD133+ stem cells to reproduce themselves ex vivo imposes substantial limitations on their use for clinical applications in muscular dystrophies. Here we report that the use of cluster-assembled nanostructured titanium dioxide (ns-TiO2) substrates, in combination with cytokine enriched medium, enables high-level expansion of circulating CD133+ stem cells in vitro. Furthermore, we demonstrate that expanded circulating CD133+ stem cells retain their in vitro capacity to differentiate into myogenic cells. The exploitation of cluster-assembled ns-TiO2 substrates for the expansion of CD133+ stem cells in vitro could therefore make the clinical application of these stem cells for the treatment of muscle diseases practical.",
keywords = "Cell culture, Muscular dystrophy, Nanotopography, Stem cell, Surface treatment, Titanium oxide",
author = "Marzia Belicchi and Silvia Erratico and Paola Razini and Mirella Meregalli and Alessandra Cattaneo and Emanuela Jacchetti and Andrea Farini and Chiara Villa and Nereo Bresolin and Laura Porretti and Cristina Lenardi and Paolo Milani and Yvan Torrente",
year = "2010",
month = "7",
doi = "10.1016/j.biomaterials.2010.03.021",
language = "English",
volume = "31",
pages = "5385--5396",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "20",

}

TY - JOUR

T1 - Ex vivo expansion of human circulating myogenic progenitors on cluster-assembled nanostructured TiO2

AU - Belicchi, Marzia

AU - Erratico, Silvia

AU - Razini, Paola

AU - Meregalli, Mirella

AU - Cattaneo, Alessandra

AU - Jacchetti, Emanuela

AU - Farini, Andrea

AU - Villa, Chiara

AU - Bresolin, Nereo

AU - Porretti, Laura

AU - Lenardi, Cristina

AU - Milani, Paolo

AU - Torrente, Yvan

PY - 2010/7

Y1 - 2010/7

N2 - Ex vivo expansion of hematopoietic stem cells has been explored in the fields of stem cell biology, gene therapy and clinical transplantation. Recently, we demonstrated the existence of a circulating myogenic progenitor expressing the CD133 antigen. The relative inability of circulating CD133+ stem cells to reproduce themselves ex vivo imposes substantial limitations on their use for clinical applications in muscular dystrophies. Here we report that the use of cluster-assembled nanostructured titanium dioxide (ns-TiO2) substrates, in combination with cytokine enriched medium, enables high-level expansion of circulating CD133+ stem cells in vitro. Furthermore, we demonstrate that expanded circulating CD133+ stem cells retain their in vitro capacity to differentiate into myogenic cells. The exploitation of cluster-assembled ns-TiO2 substrates for the expansion of CD133+ stem cells in vitro could therefore make the clinical application of these stem cells for the treatment of muscle diseases practical.

AB - Ex vivo expansion of hematopoietic stem cells has been explored in the fields of stem cell biology, gene therapy and clinical transplantation. Recently, we demonstrated the existence of a circulating myogenic progenitor expressing the CD133 antigen. The relative inability of circulating CD133+ stem cells to reproduce themselves ex vivo imposes substantial limitations on their use for clinical applications in muscular dystrophies. Here we report that the use of cluster-assembled nanostructured titanium dioxide (ns-TiO2) substrates, in combination with cytokine enriched medium, enables high-level expansion of circulating CD133+ stem cells in vitro. Furthermore, we demonstrate that expanded circulating CD133+ stem cells retain their in vitro capacity to differentiate into myogenic cells. The exploitation of cluster-assembled ns-TiO2 substrates for the expansion of CD133+ stem cells in vitro could therefore make the clinical application of these stem cells for the treatment of muscle diseases practical.

KW - Cell culture

KW - Muscular dystrophy

KW - Nanotopography

KW - Stem cell

KW - Surface treatment

KW - Titanium oxide

UR - http://www.scopus.com/inward/record.url?scp=77952583673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952583673&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2010.03.021

DO - 10.1016/j.biomaterials.2010.03.021

M3 - Article

VL - 31

SP - 5385

EP - 5396

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 20

ER -